Because androgen excess plays a fundamental role in symptoms and, it is likely, in pathogenesis of polycystic ovary syndrome, attenuation of hyperandrogenism appears to be of paramount importance in the therapy of this condition. Consistently, drugs inhibiting androgen receptor binding not only are an effective tool in hirsutism treatment but also show favorable effects on body composition and metabolic features of these women.

Use of antiandrogens as therapy for women with polycystic ovary syndrome.

MOGHETTI, Paolo
2006-01-01

Abstract

Because androgen excess plays a fundamental role in symptoms and, it is likely, in pathogenesis of polycystic ovary syndrome, attenuation of hyperandrogenism appears to be of paramount importance in the therapy of this condition. Consistently, drugs inhibiting androgen receptor binding not only are an effective tool in hirsutism treatment but also show favorable effects on body composition and metabolic features of these women.
2006
antiandrogens; polycystic ovary syndrome; hyperandrogenism; flutamide
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/231392
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 4
social impact